JAZZ News and Press, Jazz Pharmaceuticals plc From 05/10/23

Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance PR Newswire Focus on commercial execution drove 1Q23 total revenues of $892.8 million Continued adoption of Xywav ® ; net product sales increased 49% ...

2023-05-08 15:00:20 ET Summary Jazz is a commercial stage pharma that generated $3.7bn in revenues in 2022. The company made a net loss of >$200m, although on an adjusted basis net income is forecast to be >$1.2bn. There are issues surrounding lead product Xywav, indicat...

2023-05-03 14:00:06 ET Summary Avadel Pharmaceuticals has received full FDA approval for Lumryz, an extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The drug's once-nightly dosing regimen give...

Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference PR Newswire DUBLIN , May 2, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2023 RBC Capital Mar...

Jazz Pharmaceuticals to Showcase Rapidly Expanding Oncology Pipeline and Advances in Current Product Portfolio at ASCO 2023 PR Newswire Data from multiple studies of investigational bispecific drug zanidatamab, including pivotal Phase 2 biliary tract cancers (BTC) trial result...

Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023 PR Newswire DUBLIN , April 26, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 first quarter financial results on Wedne...

2023-04-26 10:00:43 ET For further details see: Zymeworks, Jazz in pact over cancer antibody zanidatamab

Jazz Pharmaceuticals to Present Advancements in Neuroscience at American Academy of Neurology Annual Meeting PR Newswire Eleven abstracts emphasize Jazz's leadership in neuroscience and commitment to advance understanding of sleep disorders, epilepsy and movement disorders ...

2023-04-13 05:02:47 ET A federal appeals court blocked part of a Texas court's ruling that would halt the access to the abortion pill mifepristone. Earlier this week, the U.S. Justice Department (DOJ) had asked the U.S. 5th Circuit Court of Appeals to halt U.S. Judge Matthew Kacsmar...

2023-04-11 08:30:43 ET Palm Beach, FL – April 11, 2023 – FinancialNewsMedia.com News Commentary –  The COVID-19 pandemic and associated social distancing norms and lockdown affected all industries globally. Although the COVID-19 pandemic negatively impa...